Vaxart, Inc. (VXRT)

Latest Insider Confidence Score

2026Q1

51.6
Bullish

Company insider confidence (by quarter)

2010Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Care Capital III LLC — 30,793,670 Feb 15, 2018
Care Capital Investments III L.P. — 30,793,670 Feb 15, 2018
Care Capital Offshore Investments III LP — 30,793,670 Feb 15, 2018
Leschly Jan — 30,793,670 Feb 15, 2018
Grasman Jeroen Nicolaas — 1,000,000 May 20, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 2, 2026 Feb 5, 2026 Cummings James F. Chief Medical Officer Sell 47.5 -7,965 -1.07% ✗ $4.8K
Feb 2, 2026 Feb 5, 2026 Berg Edward B SVP, General Counsel Sell 47.5 -9,265 -1.33% ✗ $5.6K
Feb 2, 2026 Feb 5, 2026 Tucker Sean SVP, Chief Scientific Officer Sell 47.5 -9,265 -1.16% ✗ $5.6K
Dec 4, 2025 Dec 8, 2025 Lo Steven President Sell 86.3 +97,198 5.43% ✗ $20K
Nov 17, 2025 Dec 5, 2025 Watson W. Mark Director Buy 90.0 +20,000 19.21% ✗ $8.2K
Nov 17, 2025 Nov 21, 2025 HERON ELAINE J Director Buy 91.3 +40,000 70.71% ✗ $15.9K
Jul 17, 2025 Aug 19, 2025 Finney Kevin Director Buy 95.0 +166,668 437.41% ✗ $61.9K
Jul 29, 2025 Jul 31, 2025 Watson W. Mark Director Buy 90.0 +10,000 10.62% ✗ $4.1K
Jun 13, 2025 Jun 16, 2025 Finney Kevin Director Neutral 90.0 +6,103 19.07% ✗ -
Jun 13, 2025 Jun 16, 2025 Watson W. Mark Director Neutral 90.0 +16,000 20.48% ✗ -
Jun 13, 2025 Jun 16, 2025 HERON ELAINE J Director Neutral 90.0 +16,000 39.44% ✗ -
Jun 13, 2025 Jun 16, 2025 Wheadon David E. Director Neutral 90.0 +16,000 52.03% ✗ -
Jun 13, 2025 Jun 16, 2025 Finney Michael J. Director Neutral 77.5 +16,000 2.33% ✗ -
May 19, 2025 May 20, 2025 Grasman Jeroen Nicolaas CFO Neutral 90.0 +350,000 100.00% ✗ -
May 20, 2025 Grasman Jeroen Nicolaas CFO Neutral 52.5 - 0.00% ✗ -
May 19, 2025 May 19, 2025 Lo Steven President Buy 91.3 +100,000 100.00% ✗ $49K
Mar 28, 2025 Apr 1, 2025 Cummings James F. Chief Medical Officer Sell 52.5 -3,292 -0.44% ✗ $1.4K
Mar 28, 2025 Apr 1, 2025 Tucker Sean SVP, Chief Scientific Officer Sell 52.5 -3,913 -0.49% ✗ $1.6K
Mar 24, 2025 Mar 26, 2025 Lo Steven President Neutral 90.0 +1,405,000 617.21% ✗ -
Mar 24, 2025 Mar 26, 2025 Tucker Sean SVP, Chief Scientific Officer Neutral 90.0 +406,000 101.77% ✗ -
Mar 24, 2025 Mar 26, 2025 Lee Phillip E CFO Neutral 90.0 +406,000 179.95% ✗ -
Mar 24, 2025 Mar 26, 2025 Cummings James F. Chief Medical Officer Neutral 90.0 +406,000 118.35% ✗ -
Mar 24, 2025 Mar 26, 2025 Berg Edward B SVP, General Counsel Neutral 90.0 +406,000 140.91% ✗ -
Mar 18, 2025 Mar 20, 2025 Berg Edward B SVP, General Counsel Sell 47.5 -8,050 -2.72% ✗ $4.6K
Mar 28, 2023 Mar 20, 2025 Cummings James F. Chief Medical Officer Sell 47.5 -10,039 -2.84% ✗ $6.3K
Mar 18, 2025 Mar 20, 2025 Lo Steven President Sell 46.3 -22,362 -8.94% ✗ $12.8K
Mar 18, 2025 Mar 20, 2025 Tucker Sean SVP, Chief Scientific Officer Sell 47.5 -8,050 -1.98% ✗ $4.6K
Mar 18, 2025 Mar 20, 2025 Lee Phillip E CFO Sell 47.5 -8,050 -3.45% ✗ $4.6K
Feb 2, 2025 Feb 4, 2025 Tucker Sean SVP, Chief Scientific Officer Sell 47.5 -9,242 -2.22% ✗ $6.3K
Feb 2, 2025 Feb 4, 2025 Cummings James F. Chief Medical Officer Sell 47.5 -7,964 -2.44% ✗ $5.4K
Feb 2, 2025 Feb 4, 2025 Berg Edward B SVP, General Counsel Sell 47.5 -9,242 -3.41% ✗ $6.3K
Jan 28, 2025 Jan 29, 2025 Finney Kevin Director Neutral 90.0 +32,000 100.00% ✗ -
Jan 29, 2025 Finney Kevin Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2024 Dec 17, 2024 Lee Phillip E CFO Sell 47.5 -6,132 -2.56% ✗ $3.6K
Jun 18, 2024 Jun 20, 2024 Watson W. Mark Director Buy 91.3 +20,000 34.41% ✗ $13.6K
Jun 12, 2024 Jun 13, 2024 Lee Phillip E CFO Sell 50.0 -2,007 -0.83% ✗ $1.5K
Jun 11, 2024 Jun 12, 2024 Wheadon David E. Director Neutral 90.0 +16,000 108.47% ✗ -
Jun 11, 2024 Jun 12, 2024 Finney Michael J. Director Neutral 77.5 +16,000 2.39% ✗ -
Jun 11, 2024 Jun 12, 2024 HERON ELAINE J Director Neutral 90.0 +16,000 65.13% ✗ -
Jun 11, 2024 Jun 12, 2024 Watson W. Mark Director Neutral 90.0 +16,000 37.98% ✗ -
Jun 11, 2024 Jun 12, 2024 Yedid Robert A. Director Neutral 90.0 +16,000 86.53% ✗ -
Apr 1, 2024 Tucker Sean SVP, Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Mar 28, 2024 Apr 1, 2024 Tucker Sean SVP, Chief Scientific Officer Sell 50.0 -3,902 -0.93% ✗ $5.1K
Mar 28, 2024 Apr 1, 2024 Cummings James F. Chief Medical Officer Sell 50.0 -3,292 -1.00% ✗ $4.3K
Mar 28, 2023 Mar 20, 2024 Tucker Sean SVP, Chief Scientific Officer Sell 91.3 +42,809 11.35% ✗ $38.2K
Dec 8, 2023 Mar 20, 2024 Lee Phillip E CFO Sell 91.3 +48,906 25.35% ✗ $28.7K
Dec 8, 2023 Mar 20, 2024 Cummings James F. Chief Medical Officer Sell 91.3 +50,626 18.12% ✗ $31.9K
Dec 8, 2023 Mar 20, 2024 Berg Edward B SVP, General Counsel Sell 91.3 +47,028 21.02% ✗ $35K
Mar 18, 2024 Mar 20, 2024 Lo Steven President Neutral 90.0 +250,000 100.00% ✗ -
Mar 20, 2024 Lo Steven President Neutral 52.5 - 0.00% ✗ -
Jun 26, 2023 Aug 1, 2023 Watson W. Mark Director Neutral 90.0 +7,375 21.22% ✗ -
Jun 26, 2023 Aug 1, 2023 HERON ELAINE J Director Neutral 90.0 +6,922 39.23% ✗ -
Jun 26, 2023 Aug 1, 2023 Yedid Robert A. Director Neutral 90.0 +7,375 66.35% ✗ -
Jun 26, 2023 Aug 1, 2023 Wheadon David E. Director Neutral 90.0 +7,375 100.00% ✗ -
Jun 26, 2023 Aug 1, 2023 Finney Michael J. Director Neutral 77.5 +7,375 1.11% ✗ -
Jun 12, 2023 Jun 14, 2023 Lee Phillip E CFO Neutral 90.0 +22,500 13.20% ✗ -
Mar 17, 2023 May 11, 2023 Lee Phillip E CFO Neutral 90.0 +101,652 147.86% ✗ -
Mar 17, 2023 Mar 21, 2023 Floroiu Cezar Andrei President Neutral 90.0 +367,735 432.63% ✗ -
Mar 17, 2023 Mar 21, 2023 Berg Edward B SVP, General Counsel Neutral 90.0 +187,606 100.00% ✗ -
Mar 17, 2023 Mar 21, 2023 Lee Phillip E CFO Neutral 90.0 +191,652 278.77% ✗ -
Mar 17, 2023 Mar 21, 2023 Tucker Sean SVP, Chief Scientific Officer Neutral 90.0 +189,157 100.53% ✗ -
Mar 17, 2023 Mar 21, 2023 Cummings James F. Chief Medical Officer Neutral 90.0 +194,350 444.23% ✗ -
Dec 16, 2022 Dec 30, 2022 Lee Phillip E CFO Neutral 90.0 +68,750 100.00% ✗ -
Dec 30, 2022 Lee Phillip E CFO Neutral 52.5 - 0.00% ✗ -
Dec 28, 2022 Dec 28, 2022 Watson W. Mark Director Buy 91.3 +20,000 100.00% ✗ $15.1K
Jan 10, 2022 Oct 7, 2022 Yedid Robert A. Director Sell 27.5 -1,500 -28.63% ✗ $9K
Aug 24, 2022 Aug 26, 2022 Yedid Robert A. Director Neutral 27.5 -26,240 -70.24% ✗ -
Aug 25, 2022 Aug 25, 2022 HERON ELAINE J Director Neutral 90.0 +14,750 509.68% ✗ -
Aug 25, 2022 HERON ELAINE J Director Neutral 52.5 - 0.00% ✗ -
Aug 19, 2022 Aug 22, 2022 Yedid Robert A. Director Neutral 52.5 - 0.00% ✗ -
Aug 4, 2022 Aug 8, 2022 Watson W. Mark Director Neutral 90.0 +14,750 100.00% ✗ -
Aug 4, 2022 Aug 8, 2022 Yedid Robert A. Director Neutral 90.0 +7,375 140.74% ✗ -
Aug 4, 2022 Aug 8, 2022 Wheadon David E. Director Neutral 90.0 +7,375 100.00% ✗ -
Aug 4, 2022 Aug 8, 2022 Finney Michael J. Director Neutral 77.5 +7,375 1.12% ✗ -
Aug 4, 2022 Aug 8, 2022 Davis Todd C Director Neutral 85.0 +7,375 6.22% ✗ -
Aug 4, 2022 Aug 8, 2022 Cherrington Julie M Director Neutral 90.0 +6,217 100.00% ✗ -
Aug 8, 2022 Watson W. Mark Director Neutral 52.5 - 0.00% ✗ -
Jun 22, 2022 Jun 23, 2022 Ahmad Fuad CFO Buy 91.3 +5,000 100.00% ✗ $16.1K
May 12, 2022 Ahmad Fuad CFO Neutral 52.5 - 0.00% ✗ -
Apr 22, 2022 Apr 25, 2022 Tucker Sean SVP, Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Mar 28, 2022 Mar 30, 2022 Cummings James F. Chief Medical Officer Neutral 90.0 +43,750 100.00% ✗ -
Mar 28, 2022 Mar 30, 2022 Floroiu Cezar Andrei President Neutral 90.0 +85,000 100.00% ✗ -
Mar 28, 2022 Mar 30, 2022 Tucker Sean SVP, Chief Scientific Officer Neutral 90.0 +43,750 41.90% ✗ -
Feb 15, 2022 Feb 22, 2022 Berg Edward B SVP, General Counsel Neutral 52.5 - 0.00% ✗ -
Feb 22, 2022 Berg Edward B SVP, General Counsel Neutral 52.5 - 0.00% ✗ -
Dec 22, 2021 Dec 23, 2021 Davis Todd C Director Neutral 27.5 -1,470 -1.23% ✗ -
Nov 30, 2021 Dec 1, 2021 Echerd Margaret SVP, Principal Accntng Officer Sell 13.8 -3,602 -100.00% ✓ $28.8K
Oct 12, 2021 Oct 13, 2021 Yedid Robert A. Director Neutral 27.5 -3,000 -36.41% ✗ -
Oct 7, 2021 Cummings James F. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Sep 10, 2021 Sep 13, 2021 Echerd Margaret SVP, Principal Accntng Officer Sell 13.8 -1,801 -100.00% ✓ $16.4K
Aug 20, 2021 Aug 23, 2021 Cherrington Julie M Director Neutral 52.5 - 0.00% ✗ -
Aug 23, 2021 Cherrington Julie M Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2021 Aug 11, 2021 Tucker Sean SVP, Chief Scientific Officer Sell 28.8 -10,000 -8.74% ✓ $102K
Aug 10, 2021 Aug 11, 2021 Echerd Margaret SVP, Principal Accntng Officer Sell 13.8 -1,801 -100.00% ✓ $18K
Jul 19, 2021 Jul 21, 2021 Echerd Margaret SVP, Principal Accntng Officer Sell 13.8 -1,800 -100.00% ✓ $14.4K
Jun 18, 2021 Jun 21, 2021 Finney Michael J. Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2021 Jun 17, 2021 Wheadon David E. Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2021 Jun 17, 2021 Yedid Robert A. Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2021 Jun 17, 2021 WILSON KAREN J Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2021 Jun 17, 2021 Finney Michael J. Director Neutral 52.5 - 0.00% ✗ -